Clinical Association of Chemokine (C-X-C motif) Ligand 1 (CXCL1) with Interstitial Pneumonia with Autoimmune Features (IPAF)

被引:0
|
作者
Minrui Liang
Zhixing Jiang
Qiong Huang
Lei Liu
Yu Xue
Xiaoxia Zhu
Yiyun Yu
Weiguo Wan
Haihua Yang
Hejian Zou
机构
[1] Huashan Hospital,Division of Rheumatology
[2] Fudan University,Department of Dermatology
[3] Institute of Rheumatology,Department of Pulmonology
[4] Immunology and Allergy,undefined
[5] Fudan University,undefined
[6] Huashan Hospital,undefined
[7] Fudan University,undefined
[8] Huashan Hospital,undefined
[9] Fudan University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The term “interstitial pneumonia with autoimmune features” (IPAF) has been recently proposed. We here investigate the clinical characteristics of IPAF and evaluate the clinical implications of CXCL1-CXCR2 axis in IPAF. An increased plasma level of CXCL1 was exhibited in IPAF compared to idiopathic interstitial pneumonia (IIP), chronic obstructive pulmonary disease (COPD), and healthy controls. Additionally, plasma CXCL1 levels were clinically associated with diffusing capacity of the lungs for carbon monoxide (DLCO), erythrocyte sedimentation rate (ESR), and involved parenchyma extension in IPAF. Furthermore, circulating CXCL1 levels were highest in IPAF patients with acute exacerbations. CXCR2, the chemokine receptor for CXCL1, was readily observed in inflammatory aggregates and endothelial cells in IPAF lungs, but was lower in IIP lungs and healthy lungs. Interestingly, increased CXCL1 concentrations in BALF paralleled neutrophil counts in IPAF. Overall, the plasma concentrations of CXCL1 indicated the disease activity and prognosis in IPAF. Thus, the CXCL1/CXCR2 axis appears to be involved in the progression of IPAF.
引用
收藏
相关论文
共 50 条
  • [31] MEK1/2 inhibitor inhibits neointima formation by activating miR-126-3p/C-X-C motif chemokine ligand 12 (CXCL12)/C-X-C motif chemokine receptor 4 (CXCR4) axis
    Yan, Yali
    Zhu, Mengmeng
    Ma, Jialing
    He, Xiaoyu
    Yang, Xiaoxiao
    Xu, Hongmei
    Jiang, Meixiu
    Zhang, Shuang
    Duan, Yajun
    Han, Jihong
    Chen, Yuanli
    BIOENGINEERED, 2022, 13 (04) : 11214 - 11227
  • [32] Stromal cell-derived factor-1 (chemokine C-X-C motif ligand 12) and chemokine C-X-C motif receptor 4 are required for migration of gonadotropin-releasing hormone neurons to the forebrain
    Schwarting, Gerald A.
    Henion, Timothy R.
    Nugent, J. David
    Caplan, Benjamin
    Tobet, Stuart
    JOURNAL OF NEUROSCIENCE, 2006, 26 (25): : 6834 - 6840
  • [33] Circulating Levels of Transforming Growth Factor-βeta (TGF-β) and Chemokine (C-X-C Motif) Ligand-1 (CXCL1) as Predictors of Distant Seeding of Circulating Tumor Cells in Patients with Metastatic Breast Cancer
    Divella, Rosa
    Daniele, Antonella
    Savino, Eufemia
    Palma, Fabiola
    Bellizzi, Antonia
    Giotta, Francesco
    Simone, Giovanni
    Lioce, Marco
    Quaranta, Michele
    Paradiso, Angelo
    Mazzocca, Antonio
    ANTICANCER RESEARCH, 2013, 33 (04) : 1491 - 1497
  • [34] Serum and urinary galectin-9 and C-X-C motif chemokine ligand 10
    Mehta, Pankti
    Singh, Pratibha
    Aggarwal, Amita
    LUPUS, 2022, 31 (04) : 482 - 487
  • [35] C-X-C Motif Chemokine Ligand 14 is a Unique Multifunctional Regulator of Tumor Progression
    Yang, Xiao-Yan
    Ozawa, Shigeyuki
    Kato, Yasumasa
    Maehata, Yojiro
    Izukuri, Kazuhito
    Ikoma, Takeharu
    Kanamori, Keisuke
    Akasaka, Tetsu
    Suzuki, Kenji
    Iwabuchi, Hiroshi
    Kurata, Shun-Ichi
    Katoh, Iyoko
    Sakurai, Takashi
    Kiyono, Tohru
    Hata, Ryu-Ichiro
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (08)
  • [36] C-X-C Motif Chemokine Ligand 16 Is a Potent Predictor of Outcomes in Dialysis Patients
    Liu, Wenjin
    Wang, Lulu
    Li, Xiurong
    Gao, Chaoqing
    Zhou, Jianmei
    Zhou, Jiajun
    Wang, Liang
    Sun, Zhuxing
    Chu, Hong
    Fan, Wei
    Bai, Youwei
    Yang, Junwei
    AMERICAN JOURNAL OF NEPHROLOGY, 2021, 52 (09) : 725 - 734
  • [37] Multifaceted Roles of Chemokine C-X-C Motif Ligand 7 in Inflammatory Diseases and Cancer
    Wu, Qianmiao
    Tu, Huaijun
    Li, Jian
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [38] C-X-C Motif Chemokine Ligand 6: A Preoperative Biomarker for Recurrent Glioblastoma Multiforme
    Cheng, Lei
    Li, X. D.
    Wang, S. B.
    Yang, J. M.
    Fan, Yimu
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 84 : 117 - 124
  • [39] C-X-C Motif Chemokine Ligand 12 is a Primary Determinant of Coronary Artery Dominance
    Rios, Pam
    Zanetti, Daniela
    Hilliard, Austin
    Naftaly, Jeffrey
    Prabala, Pratima
    Kho, Pik Fang
    Chang, Kyong-Mi
    Plomondon, Meg E.
    Waldo, Stephen
    Tsao, Philip S.
    CIRCULATION, 2023, 148
  • [40] The C-X-C Motif Chemokine Ligand 5, Which Exerts an Antioxidant Role by Inducing HO-1 Expression, Is C-X-C Motif Chemokine Receptor 2-Dependent in Human Prostate Stroma and Cancer Cells
    Chang, Kang-Shuo
    Chen, Syue-Ting
    Hsu, Shu-Yuan
    Sung, Hsin-Ching
    Lin, Wei-Yin
    Tsui, Ke-Hung
    Lin, Yu-Hsiang
    Hou, Chen-Pang
    Juang, Horng-Heng
    ANTIOXIDANTS, 2024, 13 (12)